Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guardant Health, Inc. stock logo
GH
Guardant Health
$50.71
-2.6%
$45.26
$20.14
$53.42
$6.45B1.442.15 million shs1.74 million shs
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$8.85
+10.8%
$7.33
$5.32
$11.64
$394.81M0.95794,000 shs766,469 shs
Tesla, Inc. stock logo
TSLA
Tesla
$300.71
-5.3%
$317.99
$182.00
$488.54
$1.02T2.4101.91 million shs144.34 million shs
Veoneer, Inc. stock logo
VNE
Veoneer
$36.95
$36.31
$19.28
$40.46
$4.14B2.241.89 million shsN/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guardant Health, Inc. stock logo
GH
Guardant Health
+2.32%+7.19%+27.71%+22.53%+80.19%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
-1.12%+4.78%-7.30%+11.19%-24.10%
Tesla, Inc. stock logo
TSLA
Tesla
-1.84%-8.90%-9.00%+18.33%+60.53%
Veoneer, Inc. stock logo
VNE
Veoneer
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guardant Health, Inc. stock logo
GH
Guardant Health
3.4803 of 5 stars
2.51.00.04.32.22.50.6
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
3.4745 of 5 stars
1.05.01.71.41.83.31.3
Tesla, Inc. stock logo
TSLA
Tesla
4.5244 of 5 stars
2.13.00.03.53.05.01.9
Veoneer, Inc. stock logo
VNE
Veoneer
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guardant Health, Inc. stock logo
GH
Guardant Health
3.00
Buy$53.766.02% Upside
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.00
Hold$6.88-22.32% Downside
Tesla, Inc. stock logo
TSLA
Tesla
2.29
Hold$298.37-0.78% Downside
Veoneer, Inc. stock logo
VNE
Veoneer
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GH, NUS, VNE, and TSLA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/1/2025
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00
6/30/2025
Tesla, Inc. stock logo
TSLA
Tesla
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$303.00
6/26/2025
Tesla, Inc. stock logo
TSLA
Tesla
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$350.00 ➝ $475.00
6/23/2025
Tesla, Inc. stock logo
TSLA
Tesla
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$190.00 ➝ $215.00
6/23/2025
Tesla, Inc. stock logo
TSLA
Tesla
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell$175.00
6/20/2025
Tesla, Inc. stock logo
TSLA
Tesla
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
6/20/2025
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00
6/13/2025
Tesla, Inc. stock logo
TSLA
Tesla
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell
6/13/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.00
6/10/2025
Tesla, Inc. stock logo
TSLA
Tesla
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00
6/9/2025
Tesla, Inc. stock logo
TSLA
Tesla
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guardant Health, Inc. stock logo
GH
Guardant Health
$739.02M8.50N/AN/A($1.13) per share-44.88
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$1.73B0.25$2.49 per share3.56$13.10 per share0.68
Tesla, Inc. stock logo
TSLA
Tesla
$97.69B9.91$3.67 per share82.01$22.89 per share13.14
Veoneer, Inc. stock logo
VNE
Veoneer
$1.66B2.50N/AN/A$7.61 per share4.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guardant Health, Inc. stock logo
GH
Guardant Health
-$436.37M-$3.39N/AN/AN/A-53.82%N/A-26.77%8/6/2025 (Estimated)
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
-$146.59M-$0.80N/A8.19N/A-2.30%6.99%3.25%8/6/2025 (Estimated)
Tesla, Inc. stock logo
TSLA
Tesla
$7.13B$1.82165.2388.7112.066.66%9.02%5.39%7/22/2025 (Estimated)
Veoneer, Inc. stock logo
VNE
Veoneer
-$385M-$3.43N/AN/AN/A-23.17%-38.99%-20.66%N/A

Latest GH, NUS, VNE, and TSLA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.43N/AN/AN/A$23.18 billionN/A
5/8/2025Q1 2025
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.15$0.23+$0.08$2.14$352.06 million$364.49 million
4/30/2025Q1 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million
4/22/2025Q1 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.53$0.27-$0.26$0.12$22.93 billion$19.34 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.242.71%N/AN/A N/A
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A
Veoneer, Inc. stock logo
VNE
Veoneer
N/AN/AN/AN/AN/A

Latest GH, NUS, VNE, and TSLA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2025
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
quarterly$0.063.5%5/30/20255/30/20256/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
4.11
3.76
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.29
2.02
1.29
Tesla, Inc. stock logo
TSLA
Tesla
0.07
2.00
1.54
Veoneer, Inc. stock logo
VNE
Veoneer
0.26
1.67
1.33

Institutional Ownership

CompanyInstitutional Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
82.84%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%
Veoneer, Inc. stock logo
VNE
Veoneer
50.03%

Insider Ownership

CompanyInsider Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
6.10%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.00%
Tesla, Inc. stock logo
TSLA
Tesla
20.70%
Veoneer, Inc. stock logo
VNE
Veoneer
3.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,021123.89 million116.33 millionNot Optionable
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
3,10049.41 million48.43 millionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
125,6653.22 billion2.55 billionOptionable
Veoneer, Inc. stock logo
VNE
Veoneer
7,099112.02 million108.39 millionOptionable

Recent News About These Companies

Veoneer appoints new CEO
Vietnam Electricity Construction Joint Stock Corp VNE
Veoneer’s Restraint Control Systems Business Being Acquired
Vietnam Electricity Construction JSC
Cheap Flights from Zurich to Vannes
Magna completes Veoneer buy
Magna completes acquisition of Veoneer Active Safety
Magna Acquires Veoneer Active Safety Business
Vietnam Electricity Construction JSC (VNE)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Guardant Health stock logo

Guardant Health NASDAQ:GH

$50.71 -1.33 (-2.56%)
Closing price 04:00 PM Eastern
Extended Trading
$51.12 +0.41 (+0.81%)
As of 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Nu Skin Enterprises stock logo

Nu Skin Enterprises NYSE:NUS

$8.85 +0.86 (+10.76%)
Closing price 03:59 PM Eastern
Extended Trading
$8.78 -0.07 (-0.85%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Tesla stock logo

Tesla NASDAQ:TSLA

$300.71 -16.95 (-5.34%)
Closing price 04:00 PM Eastern
Extended Trading
$300.44 -0.26 (-0.09%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.

Veoneer stock logo

Veoneer NYSE:VNE

Veoneer, Inc. engages in the design, development, manufacture, and sale of automotive safety electronics primarily in North America, Europe, and Asia. It offers mono-and stereo-vision cameras, night driving assist systems, advanced driver assist systems (ADAS), electronic control units, seat belt pre-tensioner electronic controllers, and ADAS software for highly automated driving (HAD) and autonomous driving (AD). The company also provides driver monitoring systems, LiDAR sensors, RoadScape positioning, and other technologies for ADAS, HAD, and AD solutions. Veoneer, Inc. was incorporated in 2017 and is headquartered in Stockholm, Sweden.